SCHEMBL30973192

SCHEMBL30973192

Clc1cc2cc(Br)ccc2nc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 2/20 0.47
▸ NT5E P21589 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ PABPC1 P11940 1/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ NPM1 P06748 1/20 0.37
▸ ALK Q9UM73 1/20 0.37
▸ PSMB5 P28074 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ DHODH Q02127 1/20 0.35
▸ SORT1 Q99523 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MALT1 Q9UDY8 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24971016 1.00 BACE1 (0.47) BACE1NT5EHTTPABPC1CYP2A6
SCHEMBL18571738 0.83 BACE1 (0.48) BACE1NT5EHTTPABPC1CYP2A6
SCHEMBL1128599 0.80 BACE1 (0.44) BACE1NT5EHTTPABPC1CYP1A2
SCHEMBL2226679 0.80 BACE1 (0.44) BACE1NT5EHTTPABPC1CYP2A6
SCHEMBL10914745 0.78 PDE3B (0.44) BACE1CYP2A6RXFP1TDP1
SCHEMBL8672 0.77 CYP1A2 (0.57) BACE1NT5EHTTCYP2A6CYP1A2
SCHEMBL1767828 0.77 KMT2A (0.61) BACE1NT5EHTTPABPC1CYP1A2
SCHEMBL4347785 0.77 BACE1 (0.58) BACE1NT5EHTTPABPC1CYP2A6
SCHEMBL29768297 0.77 BACE1 (0.58) BACE1NT5EHTTPABPC1CYP2A6
SCHEMBL1767710 0.76 ALDH1A1 (0.49) BACE1NT5EHTTCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327354-A1 GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS INSTITUT PASTEUR DE LILLE (FR) 2024-10-03 — — US disclosed
CN-118359617-A Protein arginine methyltransferase inhibitors 华润医药研究院(深圳)有限公司 2024-07-19 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327354-A1 GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS ABCB11, ABCB1, ATP4B BACE1 2987/4885NT5E 1394/4885HTT 3098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback